Indian Drug Manufacturer to Pay $50 Million for Destroying Records Before FDA Inspection
- March 26, 2021
Indian drug manufacturer Fresenius Kabi Oncology Limited (FKOL) was sentenced to pay a criminal fine of $30 million and forfeit an additional $20 million after pleading guilty to concealing and destroying records prior to a 2013 U.S. Food and Drug Administration (FDA) plant inspection, the Department of Justice announced March 23.
ARTICLE TAGS
You must be logged in to access this content.